Medela Potentia Tbk. vs Merck Tbk. — how do they compare? Medela Potentia Tbk. trades at Rp208 (market cap 2.89T, 269K 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Medela Potentia Tbk. is the larger of the two by market cap, and Medela Potentia Tbk. is more actively traded (269K versus 37.6K). Which is the better fit depends on your goals.
| MDLA | MERK | |
|---|---|---|
Market Cap | 2.89T | 1.7T |
Volume | 269K | 37.6K |
Lot | 2.69K | 376 |
Turnover | 55.76M | 144.47M |
Average Price | 207.28 | 3,842.23 |
Value | 55.76M | 144.47M |
Indicative Equilibrium Price | 208 | 3,840 |
Indicative Equilibrium Volume | 15 | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Medela Potentia Tbk. (Company) was established based on Deed of Establishment No. 04 dated August 5, 2011, of Public Notary Evy Ferdiana, S.H, Notary of Bekasi Regency, domiciled in Lemah Abang. The Company started its operation activities in 2013.
Read more on MDLA →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →